Background The diagnostic cut‐off value for chronic pulmonary Aspergillosis (CPA) by Aspergillus fumigatus‐specific IgG has never been evaluated In Taiwan. The cut‐off value for Aspergillus flavus‐specific IgG has not been evaluated worldwide. Objectives Evaluate diagnostic cut‐off value of Aspergillus IgG and its application characteristics. Patients/Methods Blood from control groups and treatment‐naïve patients with CPA infections was collected for Aspergillus‐specific IgG measurements. Controls were patients who had chest radiographic abnormalities and signs of respiratory tract infection, but were negative for Aspergillus and resolved without anti‐mould therapy. Confirmation and probability of CPA were defined according to radiological features and positivity for an Aspergillus or galactomannan index. Chest computer tomography patterns were recorded for the presence of aspergilloma or nodules, subacute invasive aspergillosis, chronic cavitary pulmonary aspergillosis and chronic fibrotic pulmonary aspergillosis. Results A total of 35 cases and 50 disease controls were included. The levels of A. fumigatus‐ and A. flavus‐specific IgG correlated with CPA progression (P < .05) but not with the presence of Aspergillus species from clinical specimens (P > .05). The best cut‐off value for A. fumigatus IgG was 21.7 mg/L with area under curve (AUC) for receiver operating characteristic curve (ROC) 0.934 and had 85.7% sensitivity and 92.0% specificity. For A. flavus IgG, the best cut‐off value was 22.1 mgA/L and the AUC was 0.928 with 88.2% sensitivity and 94.1% specificity. Conclusion The level of Aspergillus‐specific IgG correlated with radiographic characteristics in patients with CPA and the best cut‐off values compared to controls were 21.7 mgA/L for A. fumigatus‐specific IgG and 22.1 mgA/L for A. flavus‐specific IgG.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.